logo
#

Latest news with #PCI

Crumbling 4-room Ayodhya school gets PCI nod in 8 min: CBI
Crumbling 4-room Ayodhya school gets PCI nod in 8 min: CBI

Time of India

time3 hours ago

  • Business
  • Time of India

Crumbling 4-room Ayodhya school gets PCI nod in 8 min: CBI

Ahmedabad: In what the Central Bureau of Investigation (CBI) has called a "premeditated abuse of regulatory processes", a ramshackle four-room primary school in Ayodhya was approved to run a pharmacy college after an online inspection that lasted barely eight minutes. The inspection, conducted via Zoom on July 3, 2023, forms a central piece of evidence in the corruption probe against Pharmacy Council of India (PCI) president Dr Montu Kumar Patel and others. According to the preliminary enquiry triggered by a complaint from the Union ministry of health and family welfare, the PCI replaced physical site inspections with online inspections from April 2023. The CBI's findings revealed that the virtual inspection of the Ayodhya school was conducted without the principal being present, and the institute's infrastructure was even flagged as "non-compliant". Yet, the PCI allowed the institution five days to file an affidavit of compliance, and just two months later, on Sep 6, 2023, the PCI's executive committee, chaired by Dr Patel, formally approved the institute to offer a diploma in pharmacy, revealed the CBI documents. You Can Also Check: Ahmedabad AQI | Weather in Ahmedabad | Bank Holidays in Ahmedabad | Public Holidays in Ahmedabad The CBI documents further revealed a financial trail behind the sanction. CBI officers traced nearly Rs 10 lakh in cash and Rs 95,000 via three separate bank transfers to a local primary school teacher, who was tasked with managing the inspection, preparing documentation, and securing PCI approval. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Villa Prices in Dubai Might Be Lower Than You Think! Villa for sale in Dubai | Search Ads Learn More Undo The money was routed through three banks in three instalments. When CBI investigators finally visited the institute, they found it to be nothing more than a dilapidated four-room school with no faculty, no infrastructure, and no students, and clearly unfit to function as a pharmacy college. The Ayodhya case is just one among at least 23 similar approvals uncovered by the CBI across Uttar Pradesh, Madhya Pradesh, Gujarat, and Rajasthan. In all these cases, pharmacy colleges were sanctioned despite falling short of the mandatory standards. On June 30, 2025, the CBI registered a regular FIR under IPC Sections 120 B (criminal conspiracy) and 420 (cheating), and Sections 7, 7A, and 8 of the amended Prevention of Corruption Act.

Conavi Medical Applauds New American Journal of Cardiology Study Highlighting Importance of Intracoronary Imaging During PCI
Conavi Medical Applauds New American Journal of Cardiology Study Highlighting Importance of Intracoronary Imaging During PCI

Hamilton Spectator

time10 hours ago

  • Health
  • Hamilton Spectator

Conavi Medical Applauds New American Journal of Cardiology Study Highlighting Importance of Intracoronary Imaging During PCI

TORONTO, July 23, 2025 (GLOBE NEWSWIRE) — Conavi Medical Inc. (TSXV: CNVI) (OTCQB: CNVIF), a leader in hybrid intracoronary imaging technologies, is pleased to highlight the recent publication in The American Journal of Cardiology titled 'Regional Disparities and Predictors of Intracoronary Imaging Use During Percutaneous Coronary Intervention in the United States'. This comprehensive analysis, based on over 1.8 million patient records, underscores both the underutilization and growing clinical importance of intracoronary imaging (ICI) during percutaneous coronary interventions (PCI). The peer-reviewed article, authored by leading interventional cardiologists at MedStar Washington Hospital Center and other prominent U.S. institutions, found that ICI—including intravascular ultrasound (IVUS) and optical coherence tomography (OCT)—significantly improves outcomes in PCI, yet remains underused, with only 13.5% of patients receiving image-guided PCI by 2020. Importantly, the study highlights growing momentum for ICI adoption, driven in part by recent upgrades in international guidelines, including Class IA recommendations in the 2024 ESC and 2025 ACC/AHA guidelines for complex PCI cases. 'This research confirms what many in the field have long known—that intracoronary imaging is vital to delivering safe, effective interventions, especially in complex lesions,' said Thomas Looby, CEO of Conavi Medical. 'As the only commercial provider of a hybrid IVUS+OCT system, Conavi is well-positioned to support this clinical shift with our Novasight Hybrid System, which delivers co-registered IVUS and OCT imaging in real time.' Conavi's Novasight Hybrid System is designed to address many of the barriers to adoption identified in the article, including lack of technical training, procedural complexity, and imaging interpretation. By unifying IVUS and OCT in a single platform, Novasight can enable physicians to access the complementary strengths of both modalities— IVUS for plaque burden and sizing/placing stents and OCT for lesion morphology and assessing stent expansion —with a streamlined workflow. 'This landmark publication adds to the growing body of evidence in favour of image-guided PCI, and we are proud to be part of a global movement toward better, evidence-based coronary care,' added Mr. Looby. Novasight Hybrid: Designed to Overcome Adoption Barriers The journal article identifies key factors limiting the adoption of ICI—many of which Conavi Medical's Novasight Hybrid System is designed to address: To read the full study, visit: About Conavi Medical Corp.: Conavi Medical is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. Its patented Novasight Hybrid™ System is the first system to combine both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries. The Novasight Hybrid System has 510(k) clearance from the U.S. Food and Drug Administration; and regulatory approval for clinical use from Health Canada, China's National Medical Products Administration, and Japan's Ministry of Health, Labor and Welfare. For more information, visit . Cautionary Statement Regarding Forward-Looking Information This news release contains 'forward-looking statements' within the meaning of applicable Canadian and U.S. securities laws, which reflect the current expectations of management of Conavi's future growth, results of operations, performance and business prospects and opportunities. Forward-looking statements are frequently, but not always, identified by words such as 'may', 'would', 'could', 'will', 'anticipate', 'believe', 'plan', 'expect', 'intend', 'estimate', 'potential for' and similar expressions, although these words may not be present in all forward-looking statements. Forward-looking statements that appear in this release may include, without limitation, references to Conavi's plans for the commercialization of its Novasight Hybrid™ System. These forward-looking statements reflect management's current beliefs with respect to future events, and are based on information currently available to management that, while considered reasonable by management as of the date on which the statements are made, are inherently subject to significant business, economic and competitive uncertainties and contingencies which could result in actions, events, conditions, results, performance or achievements to be materially different from those projected in the forward-looking statements. Forward-looking statements involve significant risks, uncertainties and assumptions and many factors could cause Conavi's actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements. Such factors and assumptions include, but are not limited to, Conavi's ability to retain key personnel; its ability to execute on its business plans and strategies; and other factors listed in the 'Risk Factors' sections of the joint information circular of Conavi dated August 30, 2024 and in the final short form prospectus of Conavi dated April 15, 2025 (each of which may be viewed at ). Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking statements prove incorrect, actual results, performance, or achievements may vary materially from those expressed or implied by the forward-looking statements contained in this news release. These factors should be considered carefully, and prospective investors should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in the news release are based upon what management currently believes to be reasonable assumptions and Conavi has attempted to identify important factors that could cause actual actions, events, conditions, results, performance or achievements to differ materially from those described in forward-looking statements, Conavi cannot assure prospective investors that actual results, performance or achievements will be consistent with these forward-looking statements. Except as required by law, Conavi expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise. Accordingly, investors should not place undue reliance on forward-looking statements. All the forward-looking statements are expressly qualified by the foregoing cautionary statements. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

Revised schedule issued for admissions in M. Tech courses
Revised schedule issued for admissions in M. Tech courses

The Hindu

timea day ago

  • Business
  • The Hindu

Revised schedule issued for admissions in M. Tech courses

Considering requests by a section of students, the Andhra Pradesh State Council of Higher Education (APSCHE) has issued a revised schedule for admissions into M. Tech courses for the academic year 2025-26. Registration-cum-payment of processing fee for (GATE/GPAT) score card upload was opened on July 9 and it will remain open till July 25, 2025, registration and processing fee for web counselling can be done till July 26, verification of uploaded certificates, which started on July 15 will continue till July 27, web options entry can be made till July 28, changes in the options, if any, can be done on July 29, seat allotments will be released on August 1, students should report at their respective colleges between August 2 and August 4 and classes will commence from August 11, 2025. As per the revised schedule for first phase of admissions in Convener quota for candidates who qualified A.P. Post Graduate Engineering Common Entrance Test (APPGECET), registration and processing fee payment for web counselling can be done till August 1, the ongoing verification of certificates will continue till August 2, web options can be entered till August 3, change in web options can be done on August 4, seat allotments will be released on August 6, students should report at colleges from August 7 and August 11 and classes will commence from August 11. PCI nod awaited for Pharmacy courses The APSCHE has said that due to non-receipt of approvals for M. Pharmacy programmes from the Pharmacy Council of India (PCI) for the year 2025-26 to various colleges in the State, it has been decided to issue a revised schedule at a later date, exclusively for admissions into Pharmacy courses of 2025-26.

Raysut Cement reports strong H1, global gains
Raysut Cement reports strong H1, global gains

Observer

time4 days ago

  • Business
  • Observer

Raysut Cement reports strong H1, global gains

MUSCAT, JULY 19 Raysut Cement Company (RCC) Group, Oman's largest cement producer, has reported a significant financial turnaround in the first half of 2025, marking a major step in its transformation into a resilient and forward-looking industry leader. The Group's consolidated revenue rose by 30.8% to RO 41.3 million, while net losses were reduced by 38% compared to the same period in 2024. This performance reflects a successful strategy implemented across its operations, including key contributions from its UAE-based subsidiary Pioneer Cement Industries and its growing presence in the Maldives. Pioneer Cement Industries (PCI), a wholly owned subsidiary of RCC in the UAE, has become a central pillar in the Group's recovery. PCI's capacity utilisation surged to 88% in the first half of the year, up from just 40% during the same period in 2024. This turnaround is attributed to improved operational discipline and a renewed commercial focus. PCI succeeded in attracting bulk cement customers in the UAE and increased its monthly sales by an average of 50,000 metric tonnes. It also developed premium clinker products with higher margins and introduced a smart pricing mechanism to enhance competitiveness. In an interview with the Observer, Acting CEO Dr Hilal Saif al Dhamri highlighted the importance of these strategic gains. 'Pioneer Cement's recovery is a textbook example of how operational excellence and smart market positioning can deliver real results,' he said. 'We have restored its reputation and repositioned it as a high-performing, quality-driven asset within our Group.' RCC's strategic expansion into the Maldives has also paid dividends. Its 75%-owned subsidiary, Maldives Raysut Cement Company, has become a preferred supplier for major infrastructure projects in the island nation. The Group now holds a 35% share of total cement imports to the Maldives. Despite logistical hurdles typical of island markets, the company introduced efficient distribution models and launched specialised marine-grade cement to meet coastal construction demands. Dr Hilal Saif al Dhamri, Acting CEO of Raysut Cement Company 'The Maldives is a key part of our international growth strategy,' Dr Al Dhamri added. 'We've established ourselves as a reliable partner for national development projects, and our localised approach is helping us build long-term customer trust.' On the sustainability front, RCC is setting new benchmarks at its flagship Salalah plant. The company is implementing a Waste Heat Recovery System that will generate 9MW of clean electricity annually, cutting CO₂ emissions by an estimated 50,000 tonnes per year and saving around RO 1.5 million in energy costs. Alongside this, a Refuse-Derived Fuel (RDF) project is being rolled out to process about 700 tonnes of municipal waste per day into alternative fuel, replacing 15% of the plant's natural gas consumption. These initiatives support Oman's environmental goals and demonstrate the financial viability of green technology in heavy industry. At the Sohar Cement Factory, monthly sales increased by 32,000 metric tonnes, contributing to stronger Group-wide performance. Strategic price optimisation in export markets has also helped bolster revenues and create a more sustainable business model. With these achievements, RCC is entering a new phase of sustained growth under Dr Al Dhamri's leadership. 'We've laid a strong foundation by revitalising our core operations, expanding internationally, and leading on sustainability,' he noted. 'Our focus now is to accelerate our momentum and secure our position as a regional industry leader.' As 2025 progresses, Raysut Cement stands as a model of industrial transformation—one that combines operational discipline, market diversification, and environmental responsibility to drive long-term value for Oman's cement sector and the wider region.

VGS, The World's Leader in Payment Tokenization, Enables Businesses to Solve Critical Security and Payment Challenges
VGS, The World's Leader in Payment Tokenization, Enables Businesses to Solve Critical Security and Payment Challenges

CBS News

time5 days ago

  • Business
  • CBS News

VGS, The World's Leader in Payment Tokenization, Enables Businesses to Solve Critical Security and Payment Challenges

This content was provided by Acumen Media for VGS. In the past decade, nearly any consumer who has made a purchase online has likely experienced the pain of a credit or debit card breach. When this happens, merchants feel the impact, either through their bottom line or a tarnished public image. VGS helps merchants securely store and manage sensitive data to prevent those breaches. VGS is the world's leader in payment tokenization and a trusted credential management platform. Depended upon by Fortune 500 companies, merchants, fintechs and banks alike, VGS has been revolutionizing the secure storage of sensitive data since 2015. With over 5 billion tokens managed globally, VGS's mission is to transform the way sensitive data is secured, enabling organizations to manage their data across cards, bank accounts and digital wallets with seamless ease. With the VGS Vault, merchants collect, protect and exchange sensitive data from a processor-agnostic, PCI-compliant environment. This reduces a merchant's liability, insulates their business from risk exposure, minimizes fraud and alleviates compliance overhead by replacing raw data with non-sensitive tokens. The VGS Vault helps businesses scale quickly by providing them with the freedom to operate on sensitive data, including personally identifiable information (PII), without their systems ever touching it. The VGS platform helps merchants implement a strategic approach to payment orchestration, offering the flexibility to intelligently route each transaction to the ideal payment service provider (PSP). VGS gives merchants control of routing their payments, allowing them to optimize costs, improve performance and enhance security, all while providing a seamless payment experience to their valued customers. The VGS Card Management Platform is a card lifecycle management solution that provides a trusted payments infrastructure. Merchants can manage data and value-added network services to obtain the most up-to-date card-on-file information in one secure location through a single API integration. Enterprise customers with multiple data locations or PSPs are able to maintain the highest-quality card data by automatically retrieving updated card information to reduce declined transactions due to expired or changed card details. Additionally, merchants can leverage VGS's direct integrations to ensure the best response times to enrich card data. Merchants who work with VGS can expect an increase in authorization rates, more streamlined operations and a faster ROI. VGS has proudly built a platform that empowers merchants to take control of their payments strategy. Merchants can handle card payments more securely, efficiently and cost-effectively because VGS abstracts away the complexities of sensitive data management and PCI compliance, while still providing access to valuable payment network services through a unified platform. At VGS, we're not just securing payments, we're empowering businesses to unlock new possibilities in the ever-evolving payment landscape. This advertiser content was paid for and created by Acumen. Neither CBS News nor CBS News Brand Studio, the brand marketing arm of CBS News, were involved in the creation of this content.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store